Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp Prices $1.2B Senior Notes Offering

NEW YORK (GenomeWeb) – Laboratory Corporation of America today priced its offering of $1.2 billion in senior notes.

The offering consists of two tranches, a $600 million aggregate principal of 3.25 percent senior notes due in 2024, and a $600 million aggregate principal amount of 3.6 percent senior notes due in 2027. The closing of the offering is expected on Aug. 22, and LabCorp plans to use the net proceeds for general corporate purposes, including the repayment at maturity of outstanding 2.2 percent senior notes due on Aug. 23.

The joint book-running managers for the offering are Merrill Lynch, Pierce, Fenner & Smith; Wells Fargo Securities; Barclays Capital; MUFG Securities Americas; and TD Securities. The acting co-managers on the offering are Credit Suisse Securities; KeyBanc Capital Markets; PNC Capital Markets; US Bancorp Investments; BB&T Capital markets; BNY Mellon Capital Markets; Credit Agricole Securities; Fifth Third Securities; and Goldman Sachs.

In late July, LabCorp announced a deal to acquire specialty contract research organization Chiltern for about $1.2 billion in cash. 

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.